Agency News from Centron, Jocoto and Harrison and Star

Share this article:
Centron won the agency of record assignment for Cephalon's AMRIX capsules as well as the medical education agency assignment for a new product being developed by Acorda Therapeutics.

Jocoto said it has won launch assignments from Abaxis' animal health unit, IntraPace, Luminous Medical, Relievant Medical and a minimally invasive back surgery company. The San Francisco-based medical agency said it has seen a 25%-30% increase in spend since the economic downturn began in 2009.

Harrison and Star was named agency of record for the launch of Incyte's Janus-Associated Kinase inhibitor currently known as INCB18424, a first-in-class compound that, if approved, could become the first drug indicated for myleofibrosis.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions